| dc.contributor.author | Mooranian, A. | |
| dc.contributor.author | Negrulj, R. | |
| dc.contributor.author | Al-Sallami, H. | |
| dc.contributor.author | Fang, Z. | |
| dc.contributor.author | Mikov, M. | |
| dc.contributor.author | Golocorbin-Kon, S. | |
| dc.contributor.author | Fakhoury, M. | |
| dc.contributor.author | Arfuso, Frank | |
| dc.contributor.author | Al-Salami, S. | |
| dc.date.accessioned | 2017-11-24T05:25:55Z | |
| dc.date.available | 2017-11-24T05:25:55Z | |
| dc.date.created | 2017-11-24T04:48:52Z | |
| dc.date.issued | 2015 | |
| dc.identifier.citation | Mooranian, A. and Negrulj, R. and Al-Sallami, H. and Fang, Z. and Mikov, M. and Golocorbin-Kon, S. and Fakhoury, M. et al. 2015. Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014). Journal of Microencapsulation. 32 (7): pp. I-I. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/58456 | |
| dc.identifier.doi | 10.3109/02652048.2015.1084094 | |
| dc.publisher | Informa Healthcare | |
| dc.title | Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment (vol 32, pg 151, 2014) | |
| dc.type | Journal Article | |
| dcterms.source.volume | 32 | |
| dcterms.source.number | 7 | |
| dcterms.source.startPage | I | |
| dcterms.source.endPage | I | |
| dcterms.source.issn | 0265-2048 | |
| dcterms.source.title | Journal of Microencapsulation | |
| curtin.department | School of Biomedical Sciences | |
| curtin.accessStatus | Open access via publisher | |
